# Nuclide record duchembio (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/duchembio/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "duchembio" ;
  schema:name "DuChemBio"@en ;
  schema:alternateName "DuchemBio Co., Ltd."@en, "DCB"@en ;
  schema:description "Korea's biggest maker of diagnostic PET tracers, now building the country's first plant for radioactive cancer therapies."@en ;
  schema:url <https://nuclide.cc/companies/duchembio/>, <https://www.duchembio.com/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://web.archive.org/web/20220115151814/http://duchembio.com/1-3history>, <https://www.itm-radiopharma.com/news/press-releases/press-releases-detail/itm-and-dcb-sign-exclusive-licensing-development-agreement-for-solucin-in-south-korea>, <https://pharmasource.global/content/news/cdmo-news/duchembio-to-build-25-5m-radiopharmaceutical-cdmo-plant-in-south-korea/> ;
  schema:addressCountry "KR" ;
  nuclide:related <https://nuclide.cc/drugs/fludeoxyglucose-f18/>, <https://nuclide.cc/drugs/i-123-ioflupane/>, <https://nuclide.cc/companies/itm/>, <https://nuclide.cc/companies/life-molecular-imaging/>, <https://nuclide.cc/institutions/ksnm/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/lu-177/> .